Prenatal psychosocial distress is a recognized risk factor for adverse birth outcomes such as preterm birth, but biological mechanisms remain incompletely defined. The progesterone-derived neuroactive steroid allopregnanolone (ALLO) is stress-responsive and may influence pregnancy maintenance by inhibiting uterine activation and modulating inflammatory and neuroendocrine pathways involved in parturition. Few human studies have examined ALLO during pregnancy in relation to birth timing and related outcomes, and prior work has not, to the authors' knowledge, evaluated the full pathway from prenatal psychosocial distress through ALLO to birth outcomes.
This secondary analysis included 237 pregnant participants drawn from the Healthy Start cohort. The sample was enriched for psychosocial distress: 57 participants were classified as high-distress and 180 as low-distress based on screening instruments. Participants had a mean (±SD) age of 29±6 years; 38% were nulliparous, and 60% identified as non-Hispanic White. Further demographic and covariate distributions beyond these descriptors were not reported in the abstract.
Prenatal psychosocial distress was assessed using the Edinburgh Perinatal Depression Scale (EPDS) and the EPDS-3A anxiety subscale. Participants were classified into high- and low-distress groups for analysis. Specific cutoffs or timing of the questionnaire relative to gestational age beyond the general description were not provided in the abstract.
Maternal serum concentrations of ALLO and related steroid hormones were measured using a validated high-performance liquid chromatography with tandem mass spectrometry (HPLC-MS/MS) assay. Measurements were made at approximately 17 and 27 weeks' gestation, with an overall sampling range reported as 10–34 weeks. For analysis, ALLO and the ALLO-to-progesterone ratio were natural log (ln)-transformed.
The primary outcome was gestational age at birth. Secondary outcomes included birthweight-for-gestational-age z-score (BW/GA), percent fat mass (%FM), and birth length-for-gestational-age z-score (BL/GA). The only birth outcome showing an association with prenatal psychosocial distress in the reported results was BL/GA.
The investigators used regression-based mediation analyses. They compared the total effect of prenatal psychosocial distress on outcomes with the direct effect estimated after adjustment for each proposed mediator (ln-ALLO and ln ALLO-to-progesterone ratio). This allowed estimation of the change in the distress–outcome association when accounting for the mediator, yielding an attenuation percentage for each mediator. Details on covariates included in the regression models, sensitivity analyses, or assumptions tested for mediation were not detailed in the abstract and would require review of the full manuscript.
Among the outcomes assessed, prenatal psychosocial distress was associated only with shorter birth length-for-gestational-age (BL/GA), with an effect estimate of β = -0.49 (95% CI: -0.84, -0.14). When ALLO measured at approximately 27 weeks was entered into the mediation model, the association between prenatal distress and BL/GA was minimally attenuated (β = -0.46; 95% CI: -0.81, -0.10), corresponding to a 6.1% attenuation of the effect. In contrast, adjustment for the ALLO-to-progesterone ratio at ~27 weeks resulted in greater attenuation (β = -0.38; 95% CI: -0.74, -0.03), a 20.8% attenuation. Gestational age at birth, BW/GA, and %FM were not reported as being associated with prenatal psychosocial distress in the abstract.
These results suggest that maternal prenatal distress was linked to reduced fetal length accrual as reflected by lower BL/GA. The observation that the ALLO-to-progesterone ratio, but not ALLO alone, produced more substantial attenuation of the distress–BL/GA association supports the hypothesis that neurosteroid metabolism — rather than absolute ALLO concentration — may be a relevant biological pathway connecting maternal psychosocial distress to fetal linear growth. The authors propose that metabolic processing of progesterone to neuroactive steroids could underlie part of the observed association.
This report is a preprint and has not undergone peer review. The abstract does not report full model covariates, confounder control strategies, potential effect modification, or detailed sample characteristics beyond age, parity, and race/ethnicity percentages. The precise definitions or cutoffs used to classify high- versus low-distress participants were not provided in the abstract. De-identified participant data and analytic code are available from the corresponding author upon reasonable request and with approval from the Healthy Start Study and the Colorado Multiple Institutional Review Board, per the authors' data availability statement.
In this Healthy Start cohort analysis, prenatal psychosocial distress was associated with shorter birth length-for-gestational-age. Mediation analysis indicated that the ALLO-to-progesterone ratio may partially mediate this relationship, whereas ALLO alone did not materially mediate it. These findings implicate neurosteroid metabolism as a potential biological pathway linking maternal psychosocial distress to fetal linear growth. The authors emphasize that future mechanistic studies are needed to confirm and extend these observations before clinical implications can be drawn.